Medisca and EUROAPI have announced a strategic partnership aimed at increasing the availability of Active Pharmaceutical Ingredients (APIs) for pharmaceutical compounding. This collaboration seeks to address growing demand and potential supply challenges within the compounding sector. The partnership will leverage EUROAPI’s manufacturing capabilities and extensive API portfolio with Medisca’s established distribution network. Through this alliance, compounded medicine preparations in **Luxembourg** and internationally will benefit from a more reliable supply chain. The companies intend to streamline the sourcing process for pharmacies engaged in pharmaceutical compounding. This ultimately aims to enhance patient access to customized medications across **Europe** and beyond, bolstering compounding pharmacies in **France**, **Germany**, **Italy**, **Spain**, and the **United Kingdom**.